Flavia Nelson
Overview
Explore the profile of Flavia Nelson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
568
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mahmoudi F, McCarthy M, Nelson F
J Neuroimaging
. 2024 Dec;
35(1):e13252.
PMID: 39636088
Multiple sclerosis-related cognitive impairment (MSrCI) affects most patients with multiple sclerosis (MS), significantly contributing to disability and socioeconomic challenges. MSrCI manifests across all disease stages, mainly impacting working memory, information...
2.
Mahmoudi F, Mirmosayyeb O, Shaabani E, Moases Ghaffary E, Nelson F
Health Sci Rep
. 2024 Oct;
7(10):e70119.
PMID: 39377025
Background: The appearance of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) initiated the COVID-19 pandemic, resulting in millions of confirmed cases and numerous fatalities. In response, rapid vaccine development efforts...
3.
Wilken J, Traboulsee A, Nelson F, Ionete C, Kolind S, Fratto T, et al.
Mult Scler Relat Disord
. 2023 Apr;
73:104677.
PMID: 37028124
Background: Alemtuzumab is effective in reducing relapse rate and disability, but limited data exist on its effect on cognitive function in relapsing multiple sclerosis (RMS). The present study assessed neurocognitive...
4.
Sharma R, Romo M, Nelson F
Clin Case Rep
. 2023 Feb;
11(2):e6835.
PMID: 36789316
Eculizumab is approved for treatment of antibody positive neuromyelitis optica, myasthenia gravis, and hematologic disorders like paroxysmal nocturnal hemoglobinuria. Drug rash has not yet been reported as a side effect...
5.
Berry B, Joppa S, Labin E, Puram V, McCleary K, Clark H, et al.
Life (Basel)
. 2021 Nov;
11(11).
PMID: 34832996
Many autoimmune diseases can affect the central nervous system, and their varying clinical presentations often confound a straightforward diagnosis. In this report, we describe a unique presentation of CLIPPERS syndrome....
6.
Farooq H, Lenglet C, Nelson F
Front Neurol
. 2020 Dec;
11:606478.
PMID: 33329369
The robustness of brain structural networks, estimated from diffusion MRI data, may be relevant to cognition. We investigate whether measures of network robustness, such as , can explain cognitive impairment...
7.
Brod S, Lindsey J, Nelson F
Mult Scler J Exp Transl Clin
. 2019 Jun;
5(2):2055217319855755.
PMID: 31245023
Objective: Large demyelinating lesions with possible mass effect (tumefactive multiple sclerosis or tumefactive demyelination) can be mistaken for tumour-like space-occupying lesions suggesting a malignant outcome. Methods: We reviewed our own...
8.
Oh J, Ontaneda D, Azevedo C, Klawiter E, Absinta M, Arnold D, et al.
Neurology
. 2019 Feb;
92(11):519-533.
PMID: 30787160
Objective: To summarize current and emerging imaging techniques that can be used to assess neuroprotection and repair in multiple sclerosis (MS), and to provide a consensus opinion on the potential...
9.
Brod S, Lincoln J, Nelson F
J Neuroimaging
. 2019 Feb;
29(3):400-405.
PMID: 30748043
Background And Purpose: There is evidence of a relationship between promyelinating proteins and clinical multiple sclerosis (MS) activity during clinical relapse or recovery from clinical relapses. We examined the linkage...
10.
Burt R, Balabanov R, Burman J, Sharrack B, Snowden J, Oliveira M, et al.
JAMA
. 2019 Jan;
321(2):165-174.
PMID: 30644983
Importance: Hematopoietic stem cell transplantation (HSCT) represents a potentially useful approach to slow or prevent progressive disability in relapsing-remitting multiple sclerosis (MS). Objective: To compare the effect of nonmyeloablative HSCT...